Approval · Notice of Compliance 15334 · 2014
ORAVERSE: Notice of Compliance 15334
Issued February 26, 2014
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 15334
- Date
- February 26, 2014
- Company
- SeptodontSt-Maur-Des-Fosses, Val-De-Marne, France
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Alpha-adrenoreceptor blocker
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ORAVERSE | 02421666 | Marketed |
Medicinal ingredients
- PHENTOLAMINE MESYLATE 0.235 MG per ML